SymBiosis Capital Partners, LLC

BENTONVILLE, AR · Quarter end: Mar 31, 2026 · Filed with SEC: May 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$52.8M2026 Q1
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
The most recent 13F EDGAR holds under this CIK is 2026 Q1, filed 2026-05-12. Nothing has been filed since — the fund stopped filing, or it files under a different entity now. The positions below are a snapshot of that date, not a current portfolio.

SymBiosis Capital Partners, LLC reported 6 positions worth $52.8M as of March 31, 2026 (13F filed May 12, 2026). Largest holding: EVMN (55.8%). Biggest move: exit VSTM ($15.4M).

6 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 EVMNEvommune$29.4M55.80%1,280,778——-66.8%
▸ 2 IVAInventiva S.A.$13.1M24.76%2,354,000———
▸ 3 96663EURWave Life Sciences$5.4M10.30%750,000———
▸ 4 RANIRani Therapeutics$2.7M5.11%3,667,585——-28.4%
▸ 5 CLNNClene$2.1M4.03%431,094——-20.5%
▸ 6Surrozen,Surrozen$2.4K0.00%150,000———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does SymBiosis Capital Partners, LLC hold as of Q1 2026?

SymBiosis Capital Partners, LLC reported 6 positions worth $52.8M in its Q1 2026 13F filing. Largest positions: EVMN (55.8%), IVA (24.8%), 96663EUR (10.3%), RANI (5.1%) and CLNN (4.0%).

What did SymBiosis Capital Partners, LLC buy in Q1 2026?

New positions: 96663EUR.

What did SymBiosis Capital Partners, LLC sell in Q1 2026?

Reduced: RANI, CLNN and IVA. Sold out entirely: VSTM, AMPG, PGEN, NUVB and AARD (6 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.